Related references
Note: Only part of the references are listed.Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway
M. Nakamuta et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Serum Proteomics and Biomarker Discovery Across the Spectrum of Nonalcoholic Fatty Liver Disease
Lauren N. Bell et al.
HEPATOLOGY (2010)
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD
Lin Zheng et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease
E. Vilar Gomez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice
Yu Yamazaki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model
Maria Soledad Rosselli et al.
ATHEROSCLEROSIS (2009)
Inflammatory Pathways in Liver Homeostasis and Liver Injury
Frank Tacke et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2009)
SREBPs: protein interaction and SREBPs
Ryuichiro Sato
FEBS JOURNAL (2009)
Pan-Caspase Inhibitor VX-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis
Rafal P. Witek et al.
HEPATOLOGY (2009)
Adipokines in Liver Diseases
Fabio Marra et al.
HEPATOLOGY (2009)
The role of PPAR alpha in lipid metabolism and obesity: Focusing on the effects of estrogen on PPAR alpha actions
Michung Yoon
PHARMACOLOGICAL RESEARCH (2009)
Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels
Amandeep Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease
Bingning Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
John Willy Haukeland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Protective effect of bicyclol on tetracycline-induced fatty liver in mice
Hong-Yan Yu et al.
TOXICOLOGY (2009)
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
Anna Wieckowska et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice
Neel S. Singhal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Mechanisms of leptin action and leptin resistance
Martin G. Myers et al.
ANNUAL REVIEW OF PHYSIOLOGY (2008)
Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations
David Preiss et al.
CLINICAL SCIENCE (2008)
Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice
S. Franckhauser et al.
DIABETOLOGIA (2008)
Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease
Elisa Fabbrini et al.
GASTROENTEROLOGY (2008)
Insulin sensitivity: modulation by nutrients and inflammation
Simon Schenk et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption
Leon A. Adams et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
Silvia Sookoian et al.
JOURNAL OF HEPATOLOGY (2008)
Adipokines and Insulin Resistance
Katja Rabe et al.
MOLECULAR MEDICINE (2008)
Nonalcoholic fatty liver disease: Pathogenesis and potential for nuclear receptors as therapeutic targets
Jacob George et al.
MOLECULAR PHARMACEUTICS (2008)
The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
Mariana Lazo et al.
SEMINARS IN LIVER DISEASE (2008)
Nonalcoholic fatty liver disease and mitochondrial dysfunction
Yongzhong Wei et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Inflamed adipose tissue - A culprit underlying the metabolic syndrome and atherosclerosis
Birgit Gustafson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver
Nuria Morral et al.
JOURNAL OF LIPID RESEARCH (2007)
Obesity, inflammation, and insulin resistance
Steven E. Shoelson et al.
GASTROENTEROLOGY (2007)
The burden of overweight and obesity-related ill health in the UK
S. Allender et al.
OBESITY REVIEWS (2007)
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Herbert Tilg et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Epidemiology of obesity in Spain.: Dietary guidelines and strategies for prevention
Carmen Perez-Rodrigo et al.
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2006)
Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation
JK Reddy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes
L Qi et al.
DIABETES (2006)
Liver adenosine monophosphate-activated kinase-α2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin
F Andreelli et al.
ENDOCRINOLOGY (2006)
Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease
G Targher et al.
DIABETIC MEDICINE (2006)
Histopathology of pediatric nonalcoholic fatty liver disease
JB Schwinnner et al.
HEPATOLOGY (2005)
Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice
M You et al.
HEPATOLOGY (2005)
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
G Bedogni et al.
HEPATOLOGY (2005)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
E Bugianesi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice
T Masaki et al.
HEPATOLOGY (2004)
Beyond insulin resistance in NASH:: TNF-α or adiponectin?
JM Hui et al.
HEPATOLOGY (2004)
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients
M Bajaj et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
AM Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Elevated hepatocyte levels of the Forkhead box A2 (HNF-3β) transcription factor cause postnatal steatosis and mitochondrial damage
DE Hughes et al.
HEPATOLOGY (2003)
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
BA Neuschwander-Tetri et al.
HEPATOLOGY (2003)
Genetic manipulations of fatty acid metabolism in β-cells are associated with dysregulated insulin secretion
K Eto et al.
DIABETES (2002)
Steatohepatitis in obese individuals
WI Youssef et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2002)
The metabolic abnormalities associated with non-alcoholic fatty liver disease
M Haque et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2002)
Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?
S Chitturi et al.
HEPATOLOGY (2002)
Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?
CP Day
GUT (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Apolipoprotein synthesis in nonalcoholic steatohepatitis
N Charlton et al.
HEPATOLOGY (2002)
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
L Valenti et al.
GASTROENTEROLOGY (2002)
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
G Pagano et al.
HEPATOLOGY (2002)
Update on nonalcoholic fatty liver disease
AJ McCullough
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
J Crespo et al.
HEPATOLOGY (2001)
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
AJ Sanyal et al.
GASTROENTEROLOGY (2001)
Peroxisomal beta-oxidation and steatohepatitis
MS Rao et al.
SEMINARS IN LIVER DISEASE (2001)
Mitochondria in steatohepatitis
D Pessayre et al.
SEMINARS IN LIVER DISEASE (2001)
Clinical features and natural history of nonalcoholic steatosis syndromes
Y Falck-Ytter et al.
SEMINARS IN LIVER DISEASE (2001)
Etiopathogenesis of nonalcoholic steatohepatitis
S Chitturi et al.
SEMINARS IN LIVER DISEASE (2001)
Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity
C García-Monzón et al.
JOURNAL OF HEPATOLOGY (2000)
Obesity and insulin resistance
BB Kahn et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Peroxisomal Lipid Degradation via beta-and alpha-oxidation in mammals
GP Mannaerts et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2000)
Share Paper
